Page last updated: 2024-08-25

n'-methyl-2-pyridone-5-carboxamide and Cirrhosis

n'-methyl-2-pyridone-5-carboxamide has been researched along with Cirrhosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Itoh, H; Kanda, T; Notoya, M; Ono, T; Takahashi, R; Wakino, S; Yamada, K; Yoshimura, N; Yukioka, H1

Other Studies

1 other study(ies) available for n'-methyl-2-pyridone-5-carboxamide and Cirrhosis

ArticleYear
N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin?
    Clinical and experimental nephrology, 2023, Volume: 27, Issue:11

    Topics: Animals; Anti-Inflammatory Agents; Fibrosis; Interleukin-6; Kidney; Mice; NAD; Proto-Oncogene Proteins c-akt; Renal Insufficiency, Chronic; Uremic Toxins; Ureteral Obstruction

2023